» Articles » PMID: 34019949

Clinically Significant COVID-19 Following SARS-CoV-2 Vaccination in Kidney Transplant Recipients

Overview
Journal Am J Kidney Dis
Specialty Nephrology
Date 2021 May 21
PMID 34019949
Citations 27
Authors
Affiliations
Soon will be listed here.
Citing Articles

Vaccination for solid organ transplanted patients: Recommendations, efficacy, and safety.

Velikova T, Gerasoudis S, Batselova H World J Transplant. 2024; 14(4):92172.

PMID: 39697451 PMC: 11438943. DOI: 10.5500/wjt.v14.i4.92172.


Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire study.

Frolke S, Bouwmans P, Messchendorp A, Vervoort J, Abrahams A, de Vries A EClinicalMedicine. 2023; 62:102103.

PMID: 37533418 PMC: 10393559. DOI: 10.1016/j.eclinm.2023.102103.


Safely navigating kidney transplantation during the COVID-19 pandemic: the Singapore General Hospital's experience.

Tien C, Liew I, Ho Q, Thangaraju S, Rahman M, Lee C Korean J Transplant. 2023; 37(2):95-102.

PMID: 37435150 PMC: 10332278. DOI: 10.4285/kjt.23.0020.


Immunogenicity of SARS-CoV-2 Vaccine in Kidney Transplant Recipients: A Cross-Sectional Study in Korea.

Song S, Chung K, Jee Y, Chung H, Kim K, Minn D J Korean Med Sci. 2023; 38(5):e22.

PMID: 36747360 PMC: 9902664. DOI: 10.3346/jkms.2023.38.e22.


The impact of COVID-19 on kidney transplant care.

Zhang C, Kodali L, Mour G, Jadlowiec C, Mathur A Front Med (Lausanne). 2023; 9:1093126.

PMID: 36698806 PMC: 9868174. DOI: 10.3389/fmed.2022.1093126.


References
1.
. Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York. J Am Soc Nephrol. 2020; 31(6):1150-1156. PMC: 7269361. DOI: 10.1681/ASN.2020030375. View

2.
Husain S, Tsapepas D, Paget K, Chang J, John Crew R, Dube G . Postvaccine Anti-SARS-CoV-2 Spike Protein Antibody Development in Kidney Transplant Recipients. Kidney Int Rep. 2021; 6(6):1699-1700. PMC: 8062410. DOI: 10.1016/j.ekir.2021.04.017. View

3.
Baden L, El Sahly H, Essink B, Kotloff K, Frey S, Novak R . Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2020; 384(5):403-416. PMC: 7787219. DOI: 10.1056/NEJMoa2035389. View

4.
Benotmane I, Gautier-Vargas G, Cognard N, Olagne J, Heibel F, Braun-Parvez L . Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients. Kidney Int. 2021; 99(6):1487-1489. PMC: 7997264. DOI: 10.1016/j.kint.2021.03.014. View

5.
Boyarsky B, Werbel W, Avery R, Tobian A, Massie A, Segev D . Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients. JAMA. 2021; 325(17):1784-1786. PMC: 7961463. DOI: 10.1001/jama.2021.4385. View